Guidelines for Medical Examination for Cancer in Health Examination Agency(2025 Edition)
10.11735/j.issn.1004-0242.2025.09.A001
- VernacularTitle:健康体检机构防癌体检指南(2025年版)
- Author:
Wanqing CHEN
1
;
Zhijian XU
;
Qiang ZENG
;
Ni LI
;
Wei CAO
;
Kexin CHEN
;
Feng SUN
;
Yuping LIU
;
Yutong HE
;
Peng WANG
;
Shiqi TANG
;
Qun ZHANG
;
Kaifeng PAN
;
Jie HE
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,北京 100021
- Collective Name:Expert Group of Guideline for Medical Examination for Cancer in Health Examina-tion Agency;Working Group of Guideline for Medical Examination for Cancer in Health Exami-nation Agency
- Publication Type:Journal Article
- Keywords:
health examination agency;
medical examination for cancer;
early detection and treatment;
clinical guidelines
- From:
China Cancer
2025;34(9):667-697
- CountryChina
- Language:Chinese
-
Abstract:
Cancer incidence in China has been rising steadily,with a particularly heavy burden from several high-prevalence malignancies.Medical examination for cancer plays a critical role in the early detection of cancer,precancerous lesions,and precursor conditions,thereby facilitating timely diagnosis and intervention.Such examination also addresses the growing demand for person-alized cancer screening services among diverse population groups.The development of evidence-based,context-specific cancer screening guidelines is essential to enhance the standardization,quality,and equity of preventive screening practices across the country,ultimately improving out-comes in early cancer detection and treatment.Guided by the Department of Medical Emergency Response of the National Health Commission,the Guidelines for Medical Examination for Cancer in Health Examination Agency(2025 Edition)were developed under the leadership of the National Cancer Center.A multidisciplinary panel of experts formulated the guidelines in accordance with the principles and methodology of the World Health Organization Handbook for Guideline Deve-lopment.The guidelines provide evidence-based recommendations on key clinical domains:target cancers and populations,overall screening workflow,screening protocols,diagnostic technolo-gies,result interpretation,follow-up procedures,and quality control.The primary objective is to standardize cancer screening practices in health examination agency and strengthen China's ca-pacity for prevention and control of high-burden cancers.
